Lv1
40 积分 2021-08-19 加入
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy
11天前
已完结
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
11天前
已完结
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
14天前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
15天前
已完结
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth
18天前
已关闭
Antibodies to watch in 2026
21天前
已完结
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
22天前
已完结
A global view of hepatocellular carcinoma: trends, risk, prevention and management
24天前
已完结
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma
28天前
已关闭
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
28天前
已完结
皖公网安备34019202002308
